a Department of Bioethics , NIH Clinical Center.
Am J Bioeth. 2013;13(12):3-8. doi: 10.1080/15265161.2013.851578.
Debate surrounding the SUPPORT study highlights the absence of consensus regarding what information should be disclosed to potential research participants. Some commentators endorse the view that clinical research should be subject to high disclosure standards, even when it is testing standard-of-care interventions. Others argue that trials assessing standard-of-care interventions need to disclose only the information that is disclosed in the clinical care setting. To resolve this debate, it is important to identify the ethical concerns raised by clinical research and determine what consent process is needed to address them.
围绕 SUPPORT 研究的争论凸显了人们对于应该向潜在研究参与者披露哪些信息尚未达成共识。一些评论家认为,即使是在测试标准治疗干预的情况下,临床研究也应该遵守高标准的披露要求。另一些人则认为,评估标准治疗干预的试验只需披露在临床护理环境中披露的信息。为了解决这一争论,重要的是要确定临床研究引发的伦理问题,并确定需要什么样的同意程序来解决这些问题。